The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells
Nicoletta Bianchi
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorCristina Rutigliano
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorFederica Ginanni Corradini
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorElena Borsetti
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorMarina Tomassetti
Biotechnology Centre, University of Ferrara, Ferrara, Italy
Search for more papers by this authorCarlo Mischiati
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorGiordana Feriotto
Biotechnology Centre, University of Ferrara, Ferrara, Italy
Search for more papers by this authorRoberto Gambari
Department of Biochemistry and Molecular Biology,
Biotechnology Centre, University of Ferrara, Ferrara, Italy
Search for more papers by this authorNicoletta Bianchi
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorCristina Rutigliano
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorFederica Ginanni Corradini
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorElena Borsetti
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorMarina Tomassetti
Biotechnology Centre, University of Ferrara, Ferrara, Italy
Search for more papers by this authorCarlo Mischiati
Department of Biochemistry and Molecular Biology,
Search for more papers by this authorGiordana Feriotto
Biotechnology Centre, University of Ferrara, Ferrara, Italy
Search for more papers by this authorRoberto Gambari
Department of Biochemistry and Molecular Biology,
Biotechnology Centre, University of Ferrara, Ferrara, Italy
Search for more papers by this authorAbstract
The human leukaemic K562 cell line can be induced in vitro to undergo erythroid differentiation by a variety of chemical compounds, including haemin, butyric acid, 5-azacytidine and cytosine arabinoside. Differentiation of K562 cells is associated with an increased expression of embryo-fetal globin genes, such as the ζ, ε and γ globin genes. Therefore the K562 cell line has been proposed as a useful in vitro model system to determine the therapeutic potential of new differentiating compounds as well as to study the molecular mechanism(s) regulating changes in the expression of embryonic and fetal human globin genes. Inducers of erythroid differentiation which stimulate γ-globin synthesis could be considered for possible use in the experimental therapy of those haematological diseases associated with a failure in the expression of adult β-globin genes. In this paper we demonstrated that the G + C selective DNA-binding drugs chromomycin and mithramycin were powerful inducers of erythroid differentiation of K562 cells. Erythroid differentiation was associated with an increase in the accumulation of (a) Hb Gower 1 and Hb Portland and (b) γ-globin mRNA.
References
- 1 Al-Khatti, A., Papayannopoulou, T., Knitter, G., Fritsch, E.F. & Stamatoyannopoulos, G. (1988) Cooperative enhancement of F-cell formation in baboons treated with erythropoietin and hydroxyurea. Blood, 72, 817 – 819.
- 2 Bianchi, N., Passadore, M., Feriotto, G., Mischiati, C., Gambari, R. & Piva, R. (1995) Alteration of the expression of human estrogen receptor gene by distamycin. Journal of Steroid Biochemistry and Molecular Biology, 54, 211 – 215.
- 3 Bianchi, N., Passadore, M., Rutigliano, C., Feriotto, G., Mischiati, C. & Gambari, R. (1996) Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Biochemical Pharmacology, 52, 1489 – 1498.
- 4 Bianchi-Scarrà, G., Fiorentini, P., Gambari, R., Nastruzzi, C., Barbieri, R., Sessarego, M., Ravazzolo, R. & Garre, C. (1989) Isolation and characterization of a K562 cell line resistant to 1-β-D-arabinofuranosylcytosine-mediated erythroid induction. Experimental Hematology, 17, 859 – 864.
- 5 Bianchi Scarrà, G.L., Romani, M. & Coviello, D.A. (1986) Terminal erythroid differentiation in the K-562 cell line by 1-β-D-arabinofuranosylcytosine by c-myc messenger RNA decrease. Cancer Research, 46, 6327 – 6332.
- 6 Broggini, M., Ponti, M., Ottolenghi, S., D'Incalci, M., Mongelli, N. & Mantovani, R. (1989) Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Research, 17, 1051 – 1059.
- 7 Cioè, L., McNab, A., Hubbell, H.R., Meo, P., Curtis, P. & Rovera, G. (1981) Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid. Cancer Research, 41, 237 – 243.
- 8 Dervan, P.B. (1986) Design of sequence-specific DNA binding molecules. Science, 232, 464 – 471.
- 9 De Simone, J., Heller, P., Hall, L. & Zwiers, D. (1982) 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proceedings of the National Academy of Sciences of the United States of America, 79, 4428 – 4431.
- 10 Dorn, A., Affolter, M., Muller, M., Gehring, W.J. & Leupin, W. (1992) Distamycin-induced inhibition of homeodomain–DNA complexes. EMBO Journal, 11, 279 – 286.
- 11 Dover, G.J., Brusilow, S. & Samid, D. (1992) Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. New England Journal of Medicine, 327, 569 – 570.
- 12 Feriotto, G., Ciucci, A., Mischiati, C., Animati, F., Lombardi, P., Giacomini, P., Arcamone, F. & Gambari, R. (1994 a) Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues. European Journal of Pharmacology, 267, 143 – 149.DOI: 10.1016/0922-4106(94)90165-1
- 13 Feriotto, G., Mischiati, C. & Gambari, R. (1994 b) Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNase I footprinting study. Biochemical Journal, 299, 451 – 458.
- 14 Fibach, E., Prasanna, P., Rodgers, G.P. & Samid, D. (1993) Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and β-thalassemia. Blood, 82, 2203 – 2209.
- 15 Gambari, R., Amelotti, F. & Piva, R. (1985) Efficient cell proliferation and predominant accumulation of ε-globin mRNA in human leukemic K562 cells which produce mostly Hb Gower 1. Experientia, 41, 673 – 675.
- 16 Gambari, R., Barbieri, R., Buzzoni, D., Bernardi, F., Marchetti, G., Amelotti, F., Piva, R., Viola, L. & Del Senno, L. (1986) Human leukemic K562 cells: suppression of hemoglobin accumulation by a monoclonal antibody to human transferrin receptor. Biochimica et Biophysica Acta, 886, 203 – 213.DOI: 10.1016/0167-4889(86)90138-2
- 17 Gambari, R., Del Senno, L., Barbieri, R., Viola, L., Tripodi, M., Raschella, G. & Fantoni, A. (1984) Human leukemia K-562 cells: induction of erythoid differentiation by 5-azacytidine. Cell Differentiation, 14, 87 – 97.DOI: 10.1016/0045-6039(84)90033-2
- 18 Gambari, R., Raschellà, G., Biagini, R.R., Raschella, G., Biagini, R., Tripodi, M., Farace, M.G., Romeo, A. & Fantoni, A. (1983) Predominant expression of ζ and ε globin genes in human leukemia K-562(S6) variant cell line. Experientia, 39, 415 – 416.
- 19 Ikuta, T., Atweh, G., Boosalis, V., White, G.L., Da Fonseca, S., Boosalis, M., Faller, D.V. & Perrine, S.P. (1998) Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Annals of the New York Academy of Sciences, 850, 87 – 99.
- 20 Ley, T.J. (1991) The pharmacology of hemoglobin switching: of mice and men. Blood, 77, 1146 – 1152.
- 21 Lowrey, C.H. & Nienhuis, A.W. (1993) Treatment with azacytidine of patients with end stage β-thalassemia. New England Journal of Medicine, 329, 845 – 848.DOI: 10.1056/NEJM199309163291205
- 22 Lozzio, C.B. & Lozzio, B.B. (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia-chromosome. Blood, 45, 321 – 334.
- 23 Nakajima, O., Hashimoto, Y. & Iwasaki, S. (1993) Enhancement by retinoid of hemin-induced differentiation of human leukemia K562 cell line. FEBS Letters, 330, 81 – 84.DOI: 10.1016/0014-5793(93)80924-J
- 24 Passadore, M., Bianchi, N., Feriotto, G., Mischiati, C., Giacomini, P., Piva, R. & Gambari, R. (1995) Differential effects of distamycin analogues on amplification of human gene sequences by polymerase chain reaction. Biochemical Journal, 308, 513 – 519.
- 25 Passadore, M., Bianchi, N., Feriotto, G., Mischiati, C., Rutigliano, C. & Gambari, R. (1997) In vitro and in vivo binding of a CC-1065 analogue to human gene sequences: a polymerase-chain reaction study. European Journal of Pharmacology, 319, 317 – 325.DOI: 10.1016/S0014-2999(96)00849-7
- 26 Perrine, S.P., Ginder, G.D., Faller, D.V., Dover, G.H., Ikuta, T., Witkowska, H.E., Cai, S.P., Vichinsky, E.P. & Olivieri, N.F. (1993) A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. New England Journal of Medicine, 328, 81 – 86.DOI: 10.1056/NEJM199301143280202
- 27 Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease: rates and risk factor. New England Journal of Medicine, 325, 11 – 16.
- 28 Ray, R., Snyder, R.C., Thomas, S., Koller, C.A. & Miller, D.M. (1989) Mithramycin blocks protein binding and function of the SV40 early promoter. Journal of Clinical Investigation, 83, 2003 – 2007.
- 29 Rochette, J., Craig, J.E. & Thein, S.L. (1994) Fetal hemoglobin levels in adults. Blood Reviews, 8, 213 – 224.DOI: 10.1016/0268-960X(94)90109-0
- 30 Rodgers, G.P., Dover, G.J., Uyesaka, N., Noguchi, C.T., Schechter, A.N. & Neinhuis, A.W. (1993) Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cells disease. New England Journal of Medicine, 328, 73 – 80.DOI: 10.1056/NEJM199301143280201
- 31 Rodgers, G.P. & Rachmilewitz, E.A. (1995) Novel treatment options in the severe β-globin disorder. British Journal of Haematology, 91, 263 – 268.
- 32 Rutherford, T.R., Clegg, J.B. & Weatherall, D.J. (1979) K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature, 280, 164 – 165.
- 33 Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. & Erlich, H.A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487 – 491.
- 34 Sambrook, J., Fritsch, E.F. & Maniatis, T. (1981) Extraction, purification and analysis of messenger RNA from eukariotic cells. Molecular Cloning, 2nd edn, pp. 7.43 – 7.45. Cold Spring Harbor Press, New York.
- 35 Snyder, R.C., Ray, R., Blume, S. & Miller, D.M. (1991) Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry, 30, 4290 – 4297.
- 36 Torkelson, S., White, B., Faller, D.V., Phipps, K., Pantazis, C. & Perrine, S.P. (1996) Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells, Molecules and Diseases, 22, 150 – 158.DOI: 10.1006/bcmd.1996.0022
- 37 Van Dyke, M.W. & Dervan, P.B. (1983) Chromomycin, mithramycin and olivomycin binding sites on heterogeneous deoxyribonucleic acid: footprinting with (methidiumpropyl-EDTA) iron(II). Biochemistry, 22, 2373 – 2377.
- 38 Viola, L., Biagini, R., Barbieri, R. & Gambari, R. (1987) Inhibition of hemoglobin accumulation by monoclonal antibodies to the human transferrin receptor is reversed by hemin. Experimental Hematology, 15, 1145 – 1152.
- 39 Weatherall, D.J. & Clegg, J.B. (eds) (1981) The Thalassaemia Syndromes. Blackwell Scientific Publications, Oxford.
- 40 Welch, J.J., Rausher, F.J., III & Beerman, T.A. (1994) Targeting DNA-binding drugs to sequence-specific transcription factor DNA complexes. Journal of Biological Chemistry, 269, 31051 – 31058.
- 41 Wilson, J.T., Wilson, L.B., DeRiel, J.K., Villa-komaroff, L., Efstratiadis, A., Forget, B.G. & Weissman, S.M. (1978) Insertion of synthetic copies of human globin genes into bacterial plasmids. Nucleic Acids Research, 5, 563 – 581.